Market Tracker

06/28 5:16pm ET

Neurocrine Biosciences Inc (NASDAQ:NBIX)

46.77
Delayed Data
As of 4:00pm ET
 +1.21 / +2.66%
Today’s Change
37.35
Today|||52-Week Range
55.38
+20.85%
Year-to-Date
No recent news for Neurocrine Biosciences Inc.

Today’s Trading

Previous close45.56
Today’s open45.78
Day’s range45.37 - 47.22
Volume1,214,057
Average volume (3 months)1,318,369
Market cap$4.0B
Dividend yield--
Data as of 4:00pm ET, 06/28/2017

Growth & Valuation

Earnings growth (last year)-55.24%
Earnings growth (this year)-50.09%
Earnings growth (next 5 years)+47.94%
Revenue growth (last year)-24.12%
P/E ratioNM
Price/Sales223.72
Price/Book12.57

Competitors

 Today’s
change
Today’s
% change
EXASExact Sciences Corp+2.51+7.36%
BLUEbluebird bio Inc+2.20+2.06%
TECHBio-Techne Corp+1.17+0.99%
JUNOJuno Therapeutics In...+2.02+6.88%
Data as of 4:00pm ET, 06/28/2017

Financials

Next reporting dateAugust 2, 2017
EPS forecast (this quarter)-$0.64
Annual revenue (last year)$15.0M
Annual profit (last year)-$141.1M
Net profit margin-940.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Kevin Charles Gorman
President, Chief Operating &
Financial Officer
David-Alexandre C. Gros
Corporate headquarters
San Diego, California

Forecasts